entertainment -WSS

entertainment

author：knowledge 2025-08-08 10:29:09 - browse：2

a stethoscope and money – hospitals and health insurance coverage from STAT — Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

WSS

Addiction experts warn against a second 'war on drugs'

Data integrity in scientific journals requires "effort" by publishers, institutions

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Anxious about a speech? A startup wants you to pop a minty cardiac drug

JPM: CVS says Medicare Advantage patients are impacting profits

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

entertainment

entertainment

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Anxious about a speech? A startup wants you to pop a minty cardiac drug

How one medical school became remarkably diverse

The FDA must approve intranasal treatments for anaphylaxis

Medicare details structure of new drug price negotiation program

Readers respond to H5N1 and livestock movements, and more

Tori Bowie and the unacceptable rates of Black maternal death

Antibiotic resistance and the global rise in human conflict

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Criminal prosecution for violating HIPAA: an emerging threat

explore

NVIDIA and Google execs on the future of AI and drug discovery

Venture capitalist Bob Kocher on the state of digital health

How a scoliosis diagnosis changed the life of one young dancer

GSK Flovent asthma inhalers replaced by authorized generics

HIV vaccine remains elusive. Immunologists keep trying new ideas

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

explore

knowledge

leisure time

hotspot